Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

LAB

STANDARD BIOTOOLS INC.

CIK 0001162194 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$0.67
↑ 0.02 (3.51%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Technicals; Excluded: Options (no data)

Key stats

Market Cap
$262.64M
P/E Ratio
3.09
EPS
-0.20
Dividend Yield
Not covered
52W Position
4%
Beta
1.24

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
0.49
P/S
4.10
EV/Revenue
-0.12
ROE
15.7%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 4%
$0.63$1.72

Latest Financials

2025-12-31 FY
Revenue
$85.33M
Net Income
-$74.90M
Total Assets
$567.75M
Free Cash Flow
-$82.65M

Recent news